A French extension study of canakinumab in patients with Systemic Juvenile Idiopathic Arthritis who participated in the international study ACZ885G2301E1

Update Il y a 4 ans
Reference: EUCTR2014-002872-95

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this protocol is to add an extension period to provide continuous therapy and to collect safety data (collection of adverse events serious (SAE) or not (AE)) of French patients who completed the international CACZ885G2301E1 study in France.


Inclusion criteria

  • Systemic Juvenile Idiopathic Arthritis (SJIA) with active systemic manifestations

Links